CEACAM5 and familial pancreatic carcinoma: More recently, IRDye 800CW-conjugated anti-CEA Nbs have been used for tumor visualization in an orthotopic mouse model of pancreatic cancer: anti-CEA Nbs rapidly accumulated in neoplastic lesions, allowing discrimination between high- and low-CEA expressing tumors [86].